The stock of Eastman Chemical Co (EMN) has seen a -1.25% decrease in the past week, with a -4.24% drop in the past month, and a 8.61% flourish in the past quarter. The volatility ratio for the week is 2.73%, and the volatility levels for the past 30 days are at 1.89% for EMN. The simple moving average for the past 20 days is -2.64% for EMN’s stock, with a 5.80% simple moving average for the past 200 days.
Is It Worth Investing in Eastman Chemical Co (NYSE: EMN) Right Now?
Eastman Chemical Co (NYSE: EMN) has a higher price-to-earnings ratio of 13.87x compared to its average ratio, The 36-month beta value for EMN is at 1.46. Analysts have varying views on the stock, with 9 analysts rating it as a “buy,” 2 rating it as “overweight,” 7 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for EMN is 115.18M, and currently, shorts hold a 1.39% of that float. The average trading volume for EMN on November 07, 2024 was 838.86K shares.
EMN) stock’s latest price update
The stock of Eastman Chemical Co (NYSE: EMN) has increased by 2.78 when compared to last closing price of 100.88. Despite this, the company has experienced a -1.25% fall in its stock price over the last five trading sessions. seekingalpha.com reported 2024-11-01 that Eastman Chemical Company (NYSE:EMN ) Q3 2024 Earnings Conference Call November 1, 2024 8:00 AM ET Company Participants Greg Riddle – IR Mark Costa – Board Chair and CEO William McLain – EVP and CFO Conference Call Participants David Begleiter – Deutsche Bank Patrick Cunningham – Citigroup Duffy Fischer – Goldman Sachs Frank Mitsch – Fermium Research Vincent Andrews – Morgan Stanley Michael Leithead – Barclays Josh Spector – UBS Jeff Zekauskas – JPMorgan Aleksey Yefremov – KeyCorp Mike Sison – Wells Fargo Kevin McCarthy – Vertical Research Partners John Roberts – Mizuho Laurence Alexander – Jefferies Salvator Tiano – Bank of America Operator Good day, everyone, and welcome to the Third Quarter 2024 Eastman Conference Call. Today’s conference is being recorded.
Analysts’ Opinion of EMN
Many brokerage firms have already submitted their reports for EMN stocks, with BofA Securities repeating the rating for EMN by listing it as a “Neutral.” The predicted price for EMN in the upcoming period, according to BofA Securities is $119 based on the research report published on October 16, 2024 of the current year 2024.
UBS, on the other hand, stated in their research note that they expect to see EMN reach a price target of $128, previously predicting the price at $106. The rating they have provided for EMN stocks is “Buy” according to the report published on May 23rd, 2024.
Jefferies gave a rating of “Buy” to EMN, setting the target price at $125 in the report published on April 29th of the current year.
EMN Trading at -2.01% from the 50-Day Moving Average
After a stumble in the market that brought EMN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -9.45% of loss for the given period.
Volatility was left at 1.89%, however, over the last 30 days, the volatility rate increased by 2.73%, as shares sank -5.50% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +3.04% upper at present.
During the last 5 trading sessions, EMN fell by -1.25%, which changed the moving average for the period of 200-days by +19.64% in comparison to the 20-day moving average, which settled at $106.49. In addition, Eastman Chemical Co saw 15.43% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EMN starting from Killian Christopher Moore, who proposed sale 3,061 shares at the price of $105.00 back on Nov 06 ’24. After this action, Killian Christopher Moore now owns shares of Eastman Chemical Co, valued at $321,405 using the latest closing price.
Holt Adrian James, the SVP, Chf HR Ofcr of Eastman Chemical Co, sale 1,975 shares at $99.22 during a trade that took place back on Jun 03 ’24, which means that Holt Adrian James is holding 0 shares at $195,960 based on the most recent closing price.
Stock Fundamentals for EMN
Current profitability levels for the company are sitting at:
- 0.13 for the present operating margin
- 0.24 for the gross margin
The net margin for Eastman Chemical Co stands at 0.09. The total capital return value is set at 0.1. Equity return is now at value 16.08, with 5.97 for asset returns.
Based on Eastman Chemical Co (EMN), the company’s capital structure generated 0.47 points at debt to capital in total, while cash flow to debt ratio is standing at 0.24. The debt to equity ratio resting at 0.89. The interest coverage ratio of the stock is 5.56.
Currently, EBITDA for the company is 1.59 billion with net debt to EBITDA at 2.62. When we switch over and look at the enterprise to sales, we see a ratio of 1.77. The receivables turnover for the company is 7.01for trailing twelve months and the total asset turnover is 0.62. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.52.
Conclusion
In conclusion, Eastman Chemical Co (EMN) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
